Prevalence and resistance patterns of Klebsiella pneumoniae in the respiratory ICU
Official title: Prevelance of Klebsiella Pneumonie Isolates in the Respiratory Intensive Care Unit at Sohag University Hospitals
Run by Sohag University · NCT07841288 · Data updated 2026-11-12
This study tests how common Klebsiella pneumoniae is in respiratory samples from adults in the respiratory ICU and describes their antibiotic resistance and related clinical features.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | June 25, 2026 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT07841288 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18 years and older) admitted to the Respiratory ICU who have Klebsiella pneumoniae isolated from respiratory specimens.
✕Probably not a fit
Patients without a Klebsiella pneumoniae isolation or those not in the Respiratory ICU may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, non-interventional study conducted at Sohag University Hospital. It will collect respiratory specimens from adult ICU patients who have Klebsiella pneumoniae isolates and analyze how often the bacterium appears and what antimicrobial resistance profiles are seen. The researchers will describe associated clinical and epidemiological characteristics to understand patterns of infection and resistance. No treatments or interventions will be performed as part of the study.
Why it matters
Potential benefit: If successful, the study could clarify local prevalence and resistance trends to guide empiric therapy and infection control in the ICU.
How similar studies have gone: Previous similar studies have described prevalence and resistance patterns in other settings, supporting the usefulness of this approach in informing care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:Age ≥ 18 years Patients admitted to the Respiratory Intensive Care Unit Patients with Klebsiella pneumoniae isolated from respiratory specimens - Exclusion Criteria:Age \< 18 years Patients with other Gram-negative Enterobacteriaceae isolates \-
Where it's running
-
Sohag University Hospital
Sohag, Egypt Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phase 1 dose-finding test of a bivalent Klebsiella pneumoniae vaccine in healthy adults
This study will test a bivalent Klebsiella pneumoniae vaccine in healthy adults aged 18–50 to see if it is safe and triggers an immune response.
-
Fecal microbiota transplantation for treating drug-resistant pneumonia
This study is testing if adding a fecal transplant to regular antibiotic treatment can help people with drug-resistant pneumonia feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.